Stocksigma LogoStocksigma Logo

Wanbury's Tanuku API Facility Receives OAI Classification from US FDA

The US FDA has classified the inspection of Wanbury Limited鈥檚 Active Pharmaceutical Ingredient (API) facility in Tanuku, Andhra Pradesh, conducted between

Wanbury's Tanuku API Facility Receives OAI Classification from US FDA

Wanbury Ltd 路 Press Release 路 16 Nov 2026, 7:43 pm

Wanbury's Tanuku API Facility Receives OAI Classification from US FDA The US FDA has classified the inspection of Wanbury Limited鈥檚 Active Pharmaceutical Ingredient (API) facility in Tanuku, Andhra Pradesh, conducted between 13th Jul'26 and 17th Jul'26, as Official Action Indicated (OAI). According to the company's assessment, this regulatory classification will not impact business continuity or existing customer product supplies from the site. Wanbury stated it will work closely with the regulator to maintain compliance and resolve identified issues.

Original exchange filing (PDF)

More announcements from Wanbury Ltd

All Wanbury Ltd announcements